Agios Stock Down Year: Why It Fell 16% and What Next
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Learn effective strategies for planning your retirement in your 40s. Ensure a secure financial future by taking proactive steps now.
6,831 articlesBiotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
New GDP figures show fourth-quarter growth remained positive but cooled, challenging the notion of a looming slowdown...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Urban air mobility is moving from concept to capital-intensive reality. This article breaks down the battle royale: j...
Is there a true housing shortage in the United States, or is the story driven by location, price, and policy? This ar...
A trio of headline moments collided on one day, reshaping public perception and financial risk. This article breaks d...
As markets navigate a choppy start to March 2026, traders rely on the best stock scanners screeners to turn vast data...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
A U.S. Senate probe questions Binance over Iran sanctions. The exchange says its compliance systems are robust, while...
As Axogen prepares to report its Q4 2025 results, investors want clarity on growth, margins, and guidance. This artic...
Investor-focused guide to perimeter solutions earnings. Learn how revenue, margins, and cash flow shape PRM stock pro...
Jack in the Box reported softer results in its latest quarter, bringing attention to jack box's revenue sales trends....